| 3D Printing technologies for drug delivery: a review LK Prasad, H Smyth Drug development and industrial pharmacy 42 (7), 1019-1031, 2016 | 557 | 2016 |
| Physicochemical properties of mucus and their impact on transmucosal drug delivery J Leal, HDC Smyth, D Ghosh International journal of pharmaceutics 532 (1), 555-572, 2017 | 525 | 2017 |
| The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers HDC Smyth Advanced drug delivery reviews 55 (7), 807-828, 2003 | 230 | 2003 |
| Excipient development for pharmaceutical, biotechnology, and drug delivery systems A Katdare, M Chaubal CRC Press, 2006 | 198 | 2006 |
| Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics AJ Hickey, HM Mansour, MJ Telko, Z Xu, HDC Smyth, T Mulder, ... Journal of pharmaceutical sciences 96 (5), 1282-1301, 2007 | 197 | 2007 |
| Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms LM Armijo, SJ Wawrzyniec, M Kopciuch, YI Brandt, AC Rivera, NJ Withers, ... Journal of Nanobiotechnology 18, 1-27, 2020 | 166 | 2020 |
| Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes JO Morales, KR Fathe, A Brunaugh, S Ferrati, S Li, M Montenegro-Nicolini, ... The AAPS journal 19, 652-668, 2017 | 154 | 2017 |
| Controlled release pulmonary administration of curcumin using swellable biocompatible microparticles IM El-Sherbiny, HDC Smyth Molecular pharmaceutics 9 (2), 269-280, 2012 | 153 | 2012 |
| Influence of size and surface roughness of large lactose carrier particles in dry powder inhaler formulations MJ Donovan, HDC Smyth International journal of pharmaceutics 402 (1-2), 1-9, 2010 | 152 | 2010 |
| Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9 JS LaFountaine, K Fathe, HDC Smyth International journal of pharmaceutics 494 (1), 180-194, 2015 | 151 | 2015 |
| Dry powder inhaler device influence on carrier particle performance MJ Donovan, SH Kim, V Raman, HD Smyth Journal of pharmaceutical sciences 101 (3), 1097-1107, 2012 | 147 | 2012 |
| Carriers in drug powder delivery: implications for inhalation system design HDC Smyth, AJ Hickey American journal of drug delivery 3, 117-132, 2005 | 127 | 2005 |
| Aerosolizable lipid nanoparticles for pulmonary delivery of mRNA through design of experiments H Zhang, J Leal, MR Soto, HDC Smyth, D Ghosh Pharmaceutics 12 (11), 1042, 2020 | 119 | 2020 |
| Controlled pulmonary drug delivery HDC Smyth, AJ Hickey Springer Science & Business Media, 2011 | 119 | 2011 |
| Formulation and device design to increase nose to brain drug delivery ZN Warnken, HDC Smyth, AB Watts, S Weitman, JG Kuhn, RO Williams III Journal of Drug Delivery Science and Technology 35, 213-222, 2016 | 118 | 2016 |
| Biodegradable nano-micro carrier systems for sustained pulmonary drug delivery:(I) self-assembled nanoparticles encapsulated in respirable/swellable semi-IPN microspheres IM El-Sherbiny, HDC Smyth International journal of pharmaceutics 395 (1-2), 132-141, 2010 | 115 | 2010 |
| Swellable microparticles as carriers for sustained pulmonary drug delivery IM El‐Sherbiny, S McGill, HDC Smyth Journal of pharmaceutical sciences 99 (5), 2343-2356, 2010 | 113 | 2010 |
| Biodegradable pH-responsive alginate-poly (lactic-co-glycolic acid) nano/micro hydrogel matrices for oral delivery of silymarin IM El-Sherbiny, M Abdel-Mogib, AAM Dawidar, A Elsayed, HDC Smyth Carbohydrate polymers 83 (3), 1345-1354, 2011 | 108 | 2011 |
| Physical characterization of component particles included in dry powder inhalers. II. Dynamic characteristics AJ Hickey, HM Mansour, MJ Telko, Z Xu, HDC Smyth, T Mulder, ... Journal of pharmaceutical sciences 96 (5), 1302-1319, 2007 | 108 | 2007 |
| Disruption of the mucus barrier by topically applied exogenous particles SL McGill, HDC Smyth Molecular pharmaceutics 7 (6), 2280-2288, 2010 | 106 | 2010 |
Ashlee BrunaughAssistant Professor, Department of Pharmaceutical Sciences, University of MichiganВерификована је имејл адреса на med.umich.edu
Robert O. Williams IIIUniversity of Texas at AustinВерификована је имејл адреса на austin.utexas.eduIbrahim M. El-SherbinyFounding Chairman, Nanoscience Prog, Director, Center for Mat. Sci, Zewail City of Sci & TechnologyВерификована је имејл адреса на zewailcity.edu.eg
Marek OsinskiDistinguished Professor, University of New MexicoВерификована је имејл адреса на chtm.unm.edu
Tania F. Bahamondez-CanasAssociate Professor, Universidad de ValparaisoВерификована је имејл адреса на uv.cl
Zachary WarnkenUniversity of Texas College of PharmacyВерификована је имејл адреса на utexas.edu
Zhen XuUS Food and Drug AdministrationВерификована је имејл адреса на fda.hhs.gov
Jasmim LealThe University of Texas at AustinВерификована је имејл адреса на utexas.edu
Daniel F Moraga-EspinozaThe University of Texas at Austin; Universidad de ValparaísoВерификована је имејл адреса на utexas.edu
Leisha Armijo MartinTexas A&M University-Corpus ChristiВерификована је имејл адреса на tamucc.edu
Nihal BandaraSenior Lecturer in Oral Microbiology, University of BristolВерификована је имејл адреса на bristol.ac.uk
Hairui ZhangUltragenyx Pharmaceutical Inc.Верификована је имејл адреса на utexas.edu
Dea Herrera-RuizPITC, Facultad de Farmacia, UAEMВерификована је имејл адреса на uaem.mx
Dale L. HuberDistinguished Member of the Technical Staff, Sandia National LabsВерификована је имејл адреса на sandia.gov
Gennady SmolyakovResearch Associate Professor, Dept. of Electrical & Computer Engineering, University of New MexicoВерификована је имејл адреса на chtm.unm.edu
Nathan WithersPost-doc University of New MexicoВерификована је имејл адреса на unm.edu
Li DingFosun PharmaВерификована је имејл адреса на fosunpharma.com
